Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vazira Mutalova"'
Autor:
Umid Eraliev, Renat Latipov, Dilorom Tursunova, Annemarie Wasley, Danni Daniels, Umed Ismoilov, Manzura Akramova, Mehri Sultanova, Dilbar Yuldashova, Bahodir Barakaev, Vazira Mutalova, Laziz Tuychiev, Erkin Musabaev, Said Sharapov, Boris Pleshkov, Dovile Videbaek, Shahin Huseynov, Kamola Safaeva, Slavica Mijatovic-Rustempasic, Michael D. Bowen, Umesh D. Parashar, Margaret M. Cortese
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 2, Pp 503-509 (2021)
Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended a
Externí odkaz:
https://doaj.org/article/b16f99dfea7049de93df9b14630b593b
Autor:
Erkin Musabaev, Laziz Tuychiev, Manzura Akramova, Umid Eraliev, Renat Latipov, Kamola Safaeva, Annemarie Wasley, Boris Pleshkov, Vazira Mutalova, Mehri Sultanova, Dilbar Yuldashova, Michael D. Bowen, Dovile Videbaek, Dilorom Tursunova, Bahodir Barakaev, Said Sharapov, Danni S. Daniels, Umesh D. Parashar, Shahin Huseynov, Margaret M. Cortese, Umed Ismoilov, Slavica Mijatovic-Rustempasic
Publikováno v:
Hum Vaccin Immunother
Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5b8cf83673e777c1f161f623665c03
https://doi.org/10.1080/21645515.2020.1776034
https://doi.org/10.1080/21645515.2020.1776034